AJP - Regu Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 280: R1427-R1433, 2001;
0363-6119/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petkov, G. V.
Right arrow Articles by Nelson, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petkov, G. V.
Right arrow Articles by Nelson, M. T.
Vol. 280, Issue 5, R1427-R1433, May 2001

Low levels of KATP channel activation decrease excitability and contractility of urinary bladder

Georgi V. Petkov, Thomas J. Heppner, Adrian D. Bonev, Gerald M. Herrera, and Mark T. Nelson

Department of Pharmacology, The University of Vermont, College of Medicine, Burlington, Vermont 05405

Activation of ATP-sensitive potassium (KATP) channels can regulate smooth muscle function through membrane potential hyperpolarization. A critical issue in understanding the role of KATP channels is the relationship between channel activation and the effect on tissue function. Here, we explored this relationship in urinary bladder smooth muscle (UBSM) from the detrusor by activating KATP channels with the synthetic compounds N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide (ZD-6169) and levcromakalim. The effects of ZD-6169 and levcromakalim on KATP channel currents in isolated UBSM cells, on action potentials, and on related phasic contractions of isolated UBSM strips were examined. ZD-6169 and levcromakalim at 1.02 and 2.63 µM, respectively, caused half-maximal activation (K1/2) of KATP currents in single UBSM cells (see Heppner TJ, Bonev A, Li JH, Kau ST, and Nelson MT. Pharmacology 53: 170-179, 1996). In contrast, much lower concentrations (K1/2 = 47 nM for ZD-6169 and K1/2 = 38 nM for levcromakalim) caused inhibition of action potentials and phasic contractions of UBSM. The results suggest that activation of <1% of KATP channels is sufficient to inhibit significantly action potentials and the related phasic contractions.

ZD-6169; levcromakalim; incontinence; electrophysiology; guinea pig; potassium channel openers


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
K. L. Hristov, X. Cui, S. M. Brown, L. Liu, W. F. Kellett, and G. V. Petkov
Stimulation of {beta}3-adrenoceptors relaxes rat urinary bladder smooth muscle via activation of the large-conductance Ca2+-activated K+ channels
Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1344 - C1353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. M. Brown, L. M. Bentcheva-Petkova, L. Liu, K. L. Hristov, M. Chen, W. F. Kellett, A. L. Meredith, R. W. Aldrich, M. T. Nelson, and G. V. Petkov
{beta}-Adrenergic relaxation of mouse urinary bladder smooth muscle in the absence of large-conductance Ca2+-activated K+ channel
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1149 - F1157.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. S. Thorneloe, A. C. Sulpizio, Z. Lin, D. J. Figueroa, A. K. Clouse, G. P. McCafferty, T. P. Chendrimada, E. S. R. Lashinger, E. Gordon, L. Evans, et al.
N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part I
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 432 - 442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. S. Thorneloe, A. M. Knorn, P. E. Doetsch, E. S. R. Lashinger, A. X. Liu, C. T. Bond, J. P. Adelman, and M. T. Nelson
Small-conductance, Ca2+-activated K+ channel 2 is the key functional component of SK channels in mouse urinary bladder
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1737 - R1743.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Rizzuto and T. Pozzan
Microdomains of Intracellular Ca2+: Molecular Determinants and Functional Consequences
Physiol Rev, January 1, 2006; 86(1): 369 - 408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. V. Petkov, O. B. Balemba, M. T. Nelson, and G. M. Mawe
Identification of a spontaneously active, Na+-permeable channel in guinea pig gallbladder smooth muscle
Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G501 - G507.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. V. Petkov and M. T. Nelson
Differential regulation of Ca2+-activated K+ channels by {beta}-adrenoceptors in guinea pig urinary bladder smooth muscle
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1255 - C1263.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K.-E. Andersson and A. Arner
Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology
Physiol Rev, July 1, 2004; 84(3): 935 - 986.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. S. Thorneloe and M. T. Nelson
Properties of a tonically active, sodium-permeable current in mouse urinary bladder smooth muscle
Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1246 - C1257.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. M Herrera, M. J Pozo, P. Zvara, G. V Petkov, C. T Bond, J. P Adelman, and M. T Nelson
Urinary bladder instability induced by selective suppression of the murine small conductance calcium-activated potassium (SK3) channel
J. Physiol., September 15, 2003; 551(3): 893 - 903.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Gopalakrishnan, S. A. Buckner, K. L. Whiteaker, C.-C. Shieh, E. J. Molinari, I. Milicic, A. V. Daza, R. Davis-Taber, V. E. Scott, D. Sellers, et al.
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary Bladder Contractions. I. In Vitro Characterization
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 379 - 386.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. E. Brune, T. A. Fey, J. D. Brioni, J. P. Sullivan, M. Williams, W. A. Carroll, M. J. Coghlan, and M. Gopalakrishnan
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary Bladder Contractions. II. In Vivo Characterization
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 387 - 394.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online